Outcome of COVID-19 in patients with idiopathic inflammatory myopathy during the Omicron wave in China: A longitudinal observational study
Omicron did not worsen the overall outcomes of coronavirus disease for patients with idiopathic inflammatory myopathy; however, specific risk factors were identified, highlighting the need for targeted management strategies.
Authors
- Guochun Wang (ORCID: https://orcid.org/0000-0002-4616-9376)
- Linrong He (ORCID: https://orcid.org/0000-0002-9044-9340)
- Chao Sun (ORCID: https://orcid.org/0000-0002-9855-6765)
- Yangyang Wei
- Lu Zhang (ORCID: https://orcid.org/0000-0002-3644-5306)
- Ying Li (ORCID: https://orcid.org/0000-0002-7555-9031)
- Xin Lu (ORCID: https://orcid.org/0000-0001-5472-9292)
- Chunjia Li (ORCID: https://orcid.org/0000-0003-0647-3039)
- Wei Jiang (ORCID: https://orcid.org/0000-0001-9361-3444)
- Xiaolan Tian
Institutions
- Peking University (CN)
- China-Japan Friendship Hospital (CN)
Publication Details
- Journal
- PLoS ONE
- Published
- 2025-02-10
- DOI
- https://doi.org/10.1371/journal.pone.0317319
- Citations
- 1
- Primary Topic
- Inflammatory Myopathies and Dermatomyositis
- Type
- article
- Field-Weighted Citation Impact
- 1.35
Funders
- Natural Science Foundation of Beijing Municipality